Variant report

Variant	esv1806356
Chromosome Location	chr2:234649589-234658082
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234653876-234654428	HepG2	liver:	n/a	n/a
2	ATF3	chr2:234653988-234654486	A549	lung:	n/a	n/a
3	BCL3	chr2:234653958-234654499	A549	lung:	n/a	n/a
4	BCL3	chr2:234653885-234654544	A549	lung:	n/a	n/a
5	BHLHE40	chr2:234654058-234654451	HepG2	liver:	n/a	n/a
6	CEBPB	chr2:234654020-234654389	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
7	CEBPB	chr2:234653908-234654385	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
8	CEBPB	chr2:234653892-234654497	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
9	CEBPB	chr2:234653943-234654318	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
10	CEBPB	chr2:234657008-234657264	IMR90	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
11	CEBPB	chr2:234653961-234654410	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
12	CEBPB	chr2:234656935-234657273	A549	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
13	CEBPB	chr2:234653902-234654598	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
14	CEBPB	chr2:234653979-234654335	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
15	CEBPB	chr2:234656934-234657289	HepG2	liver:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
16	CEBPD	chr2:234654049-234654478	HepG2	liver:	n/a	n/a
17	CHD2	chr2:234654164-234654273	HepG2	liver:	n/a	n/a
18	CREB1	chr2:234654194-234654509	A549	lung:	n/a	n/a
19	CREB1	chr2:234653888-234654608	HepG2	liver:	n/a	n/a
20	CREB1	chr2:234653968-234654547	HepG2	liver:	n/a	n/a
21	CREB1	chr2:234654062-234654459	A549	lung:	n/a	n/a
22	CTCF	chr2:234651956-234652041	Kidney_OC	kidney:	n/a	n/a
23	CTCF	chr2:234651938-234652009	GM20000	blood:	n/a	n/a
24	EP300	chr2:234653868-234654574	HepG2	liver:	n/a	chr2:234654068-234654082
25	EP300	chr2:234653700-234654700	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
26	EP300	chr2:234653810-234654542	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
27	EP300	chr2:234653933-234654548	HepG2	liver:	n/a	chr2:234654068-234654082
28	EP300	chr2:234654030-234654453	HepG2	liver:	n/a	chr2:234654068-234654082
29	FOSL2	chr2:234654004-234654404	A549	lung:	n/a	n/a
30	FOSL2	chr2:234654000-234654628	HepG2	liver:	n/a	n/a
31	FOSL2	chr2:234653860-234654613	A549	lung:	n/a	n/a
32	FOSL2	chr2:234653946-234654485	HepG2	liver:	n/a	n/a
33	FOXA1	chr2:234653906-234654589	HepG2	liver:	n/a	n/a
34	FOXA1	chr2:234653871-234654608	HepG2	liver:	n/a	n/a
35	FOXA1	chr2:234653527-234654585	HepG2	liver:	n/a	n/a
36	FOXA1	chr2:234653830-234654570	HepG2	liver:	n/a	n/a
37	FOXA2	chr2:234653884-234654483	HepG2	liver:	n/a	n/a
38	FOXA2	chr2:234653696-234654749	HepG2	liver:	n/a	n/a
39	FOXA2	chr2:234653649-234654629	A549	lung:	n/a	n/a
40	FOXA2	chr2:234653954-234654644	A549	lung:	n/a	n/a
41	GATA3	chr2:234653885-234654644	A549	lung:	n/a	n/a
42	GATA3	chr2:234653893-234654633	A549	lung:	n/a	n/a
43	HDAC2	chr2:234653853-234654551	HepG2	liver:	n/a	n/a
44	HDAC2	chr2:234653902-234654531	HepG2	liver:	n/a	n/a
45	HEY1	chr2:234652495-234652743	K562	blood:	n/a	n/a
46	HNF4A	chr2:234653992-234654483	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
47	HNF4A	chr2:234654029-234654486	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
48	HNF4A	chr2:234653907-234654493	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
49	HNF4G	chr2:234653857-234654583	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654285-234654298
50	HNF4G	chr2:234653874-234654479	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654285-234654298

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234652669-234652719	AG04449	skin:	fetal
2	chr2:234652669-234652719	AG04449	skin:	fetal
3	chr2:234651850-234651900	HCT-116	colon:	n/a
4	chr2:234651850-234651900	SK-N-SH_RA	brain:	n/a
5	chr2:234652681-234652731	AG04449	skin:	fetal
6	chr2:234652669-234652719	HRPEpiC	eye:	n/a
7	chr2:234653891-234653941	SK-N-SH_RA	brain:	n/a
8	chr2:234652681-234652731	HNPCEpiC	eye:	n/a
9	chr2:234652363-234652413	HRPEpiC	eye:	n/a
10	chr2:234652363-234652413	HCT-116	colon:	n/a
11	chr2:234653891-234653941	GM12891	blood:	n/a
12	chr2:234652601-234652651	HMEC	breast:	n/a
13	chr2:234652466-234652516	HepG2	liver:	n/a
14	chr2:234652681-234652731	SKMC	muscle:	n/a
15	chr2:234655709-234655759	PrEC	prostate:	n/a
16	chr2:234652601-234652651	AG04449	skin:	fetal
17	chr2:234652681-234652731	CMK	blood:	n/a
18	chr2:234653891-234653941	Hela-S3	cervix:	n/a
19	chr2:234650765-234650815	NHBE	bronchial:	n/a
20	chr2:234652669-234652719	GM12892	blood:	n/a
21	chr2:234651850-234651900	Hela-S3	cervix:	n/a
22	chr2:234652466-234652516	NT2-D1	testis:	n/a
23	chr2:234655709-234655759	Caco-2	colon:	n/a
24	chr2:234655709-234655759	NH-A	brain:	n/a
25	chr2:234652601-234652651	HUVEC	blood vessel:	n/a
26	chr2:234655709-234655759	AG09309	skin:	n/a
27	chr2:234652363-234652413	T-47D	breast:	n/a
28	chr2:234652466-234652516	SK-N-SH	brain:	n/a
29	chr2:234650765-234650815	HCF	heart:	n/a
30	chr2:234653891-234653941	HEEpiC	esophagus:	n/a
31	chr2:234650765-234650815	SAEC	small airway:	n/a
32	chr2:234652669-234652719	ProgFib	skin:	n/a
33	chr2:234652681-234652731	NHDF-neo	bronchial:	n/a
34	chr2:234651850-234651900	MCF-7	breast:	n/a
35	chr2:234650765-234650815	U87	brain:	n/a
36	chr2:234652363-234652413	A549	lung:	n/a
37	chr2:234651850-234651900	LNCaP	prostate:	n/a
38	chr2:234655709-234655759	Hela-S3	cervix:	n/a
39	chr2:234651850-234651900	AG09319	gingival:	n/a
40	chr2:234655709-234655759	RPTEC	kidney:	n/a
41	chr2:234652681-234652731	HRCEpiC	kidney:	n/a
42	chr2:234652669-234652719	HCPEpiC	choroid plexus:	n/a
43	chr2:234651850-234651900	Hepatocyte	liver:	n/a
44	chr2:234650765-234650815	HPAEpiC	pulmonary alveolar:	n/a
45	chr2:234652681-234652731	HCF	heart:	n/a
46	chr2:234652681-234652731	A549	lung:	n/a
47	chr2:234655709-234655759	AG04449	skin:	fetal
48	chr2:234653891-234653941	HCT-116	colon:	n/a
49	chr2:234653891-234653941	AG04449	skin:	fetal
50	chr2:234652363-234652413	HCM	heart:	n/a

No.	Distal block	Cell Line	Cell type
1	2:234543708-234558325..2:234649753-234657866	Hela-S3	cervix:
2	chr17:63274126..63274957-chr2:234657055..234657979,2	MCF-7	breast:
3	chr2:234650134..234652973-chr2:234653062..234655371,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT1A1-2	chr2:234650166-234650603	NONHSAT077507

Variant related genes	Relation type
UGT1A2P	TF binding region
ENSG00000248705	TF binding region
DNAJB3	TF binding region
UGT1A2P	CpG island
ENSG00000248705	CpG island
DNAJB3	CpG island
ENSG00000227802	chromatin interactions
ENSG00000234143	chromatin interactions
ENSG00000242515	chromatin interactions

Extended variants
information (count: 454 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:454 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs576442434	chr2:234649623-234649624	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs192915169	chr2:234649648-234649649	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs537141786	chr2:234649649-234649650	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs17868338	chr2:234649665-234649666	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs559824040	chr2:234649747-234649748	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs528561296	chr2:234649764-234649765	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs200537082	chr2:234649775-234649776	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs28900368	chr2:234649808-234649809	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs565131356	chr2:234649870-234649871	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs28900369	chr2:234649878-234649879	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs530886202	chr2:234649886-234649887	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs551312228	chr2:234649905-234649906	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs184999730	chr2:234649956-234649957	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs536876139	chr2:234649958-234649959	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs546865407	chr2:234649976-234649977	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs565810764	chr2:234650004-234650005	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs190389633	chr2:234650015-234650016	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs564848260	chr2:234650016-234650017	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs386656370	chr2:234650101-234650102	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs557790582	chr2:234650103-234650104	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs577572519	chr2:234650112-234650113	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs28900370	chr2:234650119-234650120	Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs574132609	chr2:234650124-234650125	Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs4663963	chr2:234650193-234650194	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs28900371	chr2:234650208-234650209	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs559274983	chr2:234650221-234650222	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
27	rs569891780	chr2:234650225-234650226	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
28	rs370534544	chr2:234650231-234650232	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
29	rs77630472	chr2:234650232-234650233	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
30	rs4663964	chr2:234650236-234650237	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs181856113	chr2:234650320-234650321	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
32	rs565346181	chr2:234650341-234650342	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
33	rs28900372	chr2:234650349-234650350	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
34	rs530950175	chr2:234650364-234650365	Weak transcription	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
35	rs184800720	chr2:234650412-234650413	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
36	rs561601493	chr2:234650453-234650454	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
37	rs148818380	chr2:234650480-234650481	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
38	rs547216882	chr2:234650482-234650483	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
39	rs566953182	chr2:234650514-234650515	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
40	rs539186110	chr2:234650559-234650560	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
41	rs34352510	chr2:234650562-234650563	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs570984186	chr2:234650590-234650591	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
43	rs188089498	chr2:234650595-234650596	Weak transcription Genic enhancers	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
44	rs386656371	chr2:234650604-234650605	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs115311938	chr2:234650605-234650606	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs573640732	chr2:234650652-234650653	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs115965783	chr2:234650662-234650663	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs553186051	chr2:234650685-234650686	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs371861111	chr2:234650693-234650694	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs146940550	chr2:234650698-234650699	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Pancreatic cancer	17952125	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:48 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234620400-234659200	Weak transcription	Colonic Mucosa	Colon
2	chr2:234620600-234652200	Weak transcription	Esophagus	oesophagus
3	chr2:234626200-234649600	Weak transcription	Rectal Mucosa Donor 29	rectum
4	chr2:234626600-234668400	Weak transcription	NHEK	skin
5	chr2:234646400-234651000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr2:234646400-234666600	Weak transcription	Stomach Mucosa	stomach
7	chr2:234647800-234652200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr2:234647800-234655000	Weak transcription	Gastric	stomach
9	chr2:234648000-234649800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr2:234648600-234650400	Weak transcription	Liver	Liver
11	chr2:234649600-234649800	Enhancers	Rectal Mucosa Donor 29	rectum
12	chr2:234649800-234652200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr2:234649800-234658800	Weak transcription	Rectal Mucosa Donor 29	rectum
14	chr2:234650400-234652600	Genic enhancers	Liver	Liver
15	chr2:234651000-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr2:234652200-234652600	ZNF genes & repeats	iPS DF 6.9 Cell Line	embryonic stem cell
17	chr2:234652200-234652600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr2:234652200-234652600	ZNF genes & repeats	Esophagus	oesophagus
19	chr2:234652200-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr2:234652400-234652600	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr2:234652600-234654400	Enhancers	Liver	Liver
22	chr2:234652600-234654600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr2:234652800-234658200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr2:234652800-234659200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr2:234653200-234654400	Enhancers	HepG2	liver
26	chr2:234653200-234655600	Enhancers	Fetal Intestine Small	intestine
27	chr2:234653400-234653800	Enhancers	A549	lung
28	chr2:234653800-234654200	Active TSS	A549	lung
29	chr2:234654200-234654800	Enhancers	Small Intestine	intestine
30	chr2:234654200-234655000	Enhancers	A549	lung
31	chr2:234654200-234655400	Enhancers	Duodenum Mucosa	Duodenum
32	chr2:234654200-234655400	Enhancers	Fetal Intestine Large	intestine
33	chr2:234654400-234654600	Flanking Active TSS	HepG2	liver
34	chr2:234654400-234656000	Flanking Active TSS	Liver	Liver
35	chr2:234654600-234655800	Bivalent Enhancer	HepG2	liver
36	chr2:234655000-234655200	Flanking Active TSS	A549	lung
37	chr2:234655000-234655600	Enhancers	Gastric	stomach
38	chr2:234655200-234655400	Enhancers	A549	lung
39	chr2:234655400-234655600	Flanking Active TSS	A549	lung
40	chr2:234655400-234656200	Enhancers	Pancreas	Pancrea
41	chr2:234655600-234656200	Enhancers	A549	lung
42	chr2:234656000-234656600	Enhancers	Liver	Liver
43	chr2:234656200-234659000	Weak transcription	A549	lung
44	chr2:234656600-234657000	Flanking Active TSS	Liver	Liver
45	chr2:234657000-234657200	Enhancers	Liver	Liver
46	chr2:234657200-234657600	Flanking Active TSS	Liver	Liver
47	chr2:234657600-234658000	Active TSS	Liver	Liver
48	chr2:234658000-234658200	Flanking Active TSS	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links